Literature DB >> 3988727

The role of surface charge on the accelerating action of heparin on the antithrombin III-inhibited activity of alpha-thrombin.

C C Heuck, U Schiele, D Horn, D Fronda, E Ritz.   

Abstract

We have compared surface charge and the surface charge density on the polyanions heparin and potassium polyvinyl sulfate (KPVS), as well as on hydrolyzed heparin and KPVS, with their accelerating effect on the inhibitory action of antithrombin III on thrombin. Polyelectrolyte titration of thrombin with KPVS or heparin at pH 7.4 clearly indicates an electrostatic interaction. In contrast, at the same pH no electrostatic interaction is observed between polyanions and antithrombin III. KPVS accelerates the inhibitory action of antithrombin III to the same extent as heparin on the basis of charge equivalence. Heparin and KPVS with a mean distance between two charged centers of less than 0.75 and 0.95 nm, respectively, accelerate strongly whereas hydrolysates with lower charge densities are far less active. The following observations are indicated. Intramolecular neutralization of oppositely charged residues occurs within thrombin, antithrombin III, and partially hydrolyzed heparin. Heparin acts on the antithrombin III-thrombin reaction through cooperative electrostatic binding to thrombin and nonelectrostatic interaction with antithrombin III. This indicates a quasi-catalytic action of the polyelectrolyte. Hydrolysis of only a few N-sulfate residues within the heparin molecule decreases the linear surface charge density to such an extent that the accelerating action is drastically reduced. The loss of accelerating capacity agrees with the sudden loss of counterion condensation due to the decrease of the linear surface charge density beyond limits postulated by Manning in a theory of polyelectrolytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988727

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.

Authors:  M F Scully; V Ellis; N Seno; V V Kakkar
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

2.  An integrated microfluidic platform for selective and real-time detection of thrombin biomarkers using a graphene FET.

Authors:  Niazul I Khan; Mohammad Mousazadehkasin; Sujoy Ghosh; John G Tsavalas; Edward Song
Journal:  Analyst       Date:  2020-05-13       Impact factor: 4.616

Review 3.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

4.  Polyphosphate Initiates Tau Aggregation through Intra- and Intermolecular Scaffolding.

Authors:  Sanjula P Wickramasinghe; Justine Lempart; Hope E Merens; Jacob Murphy; Philipp Huettemann; Ursula Jakob; Elizabeth Rhoades
Journal:  Biophys J       Date:  2019-07-24       Impact factor: 4.033

5.  Heparin enhances the catalytic activity of des-ETW-thrombin.

Authors:  C A Goodwin; J J Deadman; B F Le Bonniec; S Elgendy; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

6.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

7.  Endothelial binding sites for heparin. Specificity and role in heparin neutralization.

Authors:  T Bârzu; J L Van Rijn; M Petitou; P Molho; G Tobelem; J P Caen
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

8.  RNA binding specificity of Ebola virus transcription factor VP30.

Authors:  Julia Schlereth; Arnold Grünweller; Nadine Biedenkopf; Stephan Becker; Roland K Hartmann
Journal:  RNA Biol       Date:  2016-06-17       Impact factor: 4.652

9.  Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.

Authors:  P Hovingh; M Piepkorn; A Linker
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

10.  Synthesis and anticoagulant activity of polyureas containing sulfated carbohydrates.

Authors:  Yongshun Huang; Maureen A Shaw; Eric S Mullins; Terence L Kirley; Neil Ayres
Journal:  Biomacromolecules       Date:  2014-11-05       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.